Emerging Biotechs

Website

http://www.emergingbiotechs.com

Last 50 Posts by Emerging Biotechs:

• »Medicare and Medicaid Waste in Focus as CMS Administrator Departs Position
  08 Dec 2011 in Biotech
  
• »22nd Century Rival Star Scientific Takes Public Pummeling
  15 Jul 2011 in Biotech
  
• »Unilife Commences Unifill Syringe Supply to Sanofi
  15 Jul 2011 in Biotech
  
• »Cardiology News: Cardiologist Need for Predictive Technology
  29 Jun 2011 in Biotech
  
• »The True Value of a SPA: An Inside Look at CorMedix, Inc.
  29 Jun 2011 in Biotech
  
• »CorMedix Receives SPA from FDA for Deferiprone Phase 3 trial
  24 Jun 2011 in Biotech
  
• »Former FDA Chief Kessler Urges Clampdown on Nicotine Levels; 22nd Century’s Rx-Cigs Meet the Mark
  22 Jun 2011 in Biotech
  
• »HEALTHCARE MEGATRENDS: Early Detection of At-Risk Heart Patients
  09 Jun 2011 in Biotech
  
• »SQI Diagnostics Receives FDA Clearance for Celiac Qualitative Assay
  07 Jun 2011 in Biotech
  
• »Unilife Device Chosen for Clinical Trial
  07 Jun 2011 in Biotech
  
• »Ventrus Biosciences May Reap Benefits from Uroplasty Efforts
  06 Jun 2011 in Biotech & Current Market News
  
• »Kevetrin™ Showcased By Toxicon; Cellceutix Update
  06 Jun 2011 in Biotech
  
• »Nuvilex Reports Positive Phase 2 Data for Pancreatic Cancer Treatment
  01 Jun 2011 in Biotech & Current Market News
  
• »Unilife Presenting at 2011 Jefferies Global Healthcare Conference
  01 Jun 2011 in Biotech & Current Market News
  
• »Misonix, Inc.: IP Award and New Targets of Opportunity
  27 May 2011 in Biotech & Current Market News
  
• »Around the Web: Michael J. Ray Comments on Keryx and Antares
  26 May 2011 in Biotech
  
• »Access Pharma Expanding Distribution of Mucositis Treatment
  26 May 2011 in Biotech & Current Market News
  
• »Green Baron Names Nuvilex Stock Pick of 2011
  24 May 2011 in Biotech
  
• »Cellceutix CEO States “Full Speed Ahead”
  23 May 2011 in Biotech & Current Market News
  
• »IPO Update – Ventrus Biosciences ($VTUS) @ Inside Bio
  20 May 2011 in Biotech & Current Market News
  
• »Agenus Announces Presentation of New Phase 2 Trial Data on Glioma Vaccine
  20 May 2011 in Biotech & Current Market News
  
• »Vycor Protects Brain Retractor Technology with Chinese Patent
  20 May 2011 in Biotech & Current Market News
  
• »How does the US Court of Appeal decision affect NeoStem ($NBS)?
  20 May 2011 in Biotech & Current Market News
  
• »Unilife to Present at 2011 UBS Global Specialty Pharmaceuticals Conference
  20 May 2011 in Biotech & Current Market News
  
• »Cellceutix Drug Slows Tumor Growth by 100% in Head and Neck Cancer
  20 May 2011 in Biotech & Current Market News
  
• »“Personalized Medicine” Trend Shift Presents Opportunity for Device Manufacturers
  20 May 2011 in Biotech & Current Market News
  
• »Access Pharma’s Cobraxane Shows Superior Tumor Growth Inhibition
  10 May 2011 in Biotech
  
• »Stem Cell Controversy: NeoStem, Others Get Volatile from Legal War of Words
  10 May 2011 in Biotech & Current Market News
  
• »Unilife Corp Aiming to Lower Occupational Risk for Nurses
  10 May 2011 in Biotech & Current Market News
  
• »Unilife to Announce Fiscal 2011 Q3 Results Via Webcast
  10 May 2011 in Biotech & Current Market News
  
• »Cellceutix Forwards Cancer Drug Study Protocol to Clinical Site
  09 May 2011 in Biotech & Current Market News
  
• »Vicor’s ($VCRT) FDA 510(k) Approval Signals Expanded, Ongoing Revenues
  09 May 2011 in Biotech & Current Market News
  
• »Prima BioMed (ASX:PRR) Aiming to Provide Ovarian Cancer Solution
  09 May 2011 in Biotech & Current Market News
  
• »Cellceutix Cancer Drug Trumps Competitors
  28 Apr 2011 in Biotech & Current Market News
  
• »Vicor Technologies: Quiet with Investment Community, not within Medical Industry
  28 Apr 2011 in Biotech & Current Market News
  
• »CytRx’s ($CYTR) INNO-206 Receives FDA Approval for Orphan Drug Designation for Pancreatic Cancer
  28 Apr 2011 in Biotech & Current Market News
  
• »NeoStem Subsidiary Honored with Awards
  28 Apr 2011 in Biotech & Current Market News
  
• »Superbugs Still Outwitting Hospitals ($BONU)
  21 Apr 2011 in Biotech & Current Market News
  
• »Investors Eyes Falling Regularly Upon DARA BioSciences ($DARA)
  20 Apr 2011 in Biotech & Current Market News
  
• »PharmStar (PHAR.PK) Seeks New Facility to Expedite AQUAPRIN™ Marketing
  20 Apr 2011 in Biotech & Current Market News
  
• »Cellceutix CEO, Leo Ehrlich, Conducts Interview with “Biotech Stock Trader”; Dr. Paul Ginsberg, (Renowned Patent Attorney) Joins Cellceutix Advisory Board
  18 Apr 2011 in Biotech & Current Market News
  
• »French Study Highlights Value of Access Pharmaceuticals’ Anti-Cancer Drug ProLindac
  14 Apr 2011 in Biotech & Current Market News
  
• »Bioheart Releases Corporate Power Point Presentation
  14 Apr 2011 in Biotech & Current Market News
  
• »Cellceutix Poster Presentation on its p53 Cancer Breakthrough Attracts Wide Interest at 102nd AACR Meeting
  11 Apr 2011 in Biotech & Current Market News
  
• »Bioheart: An Industry Leader and Heart Failure Specialist
  09 Apr 2011 in Biotech & Current Market News
  
• »Disease Management and Unilife Corporation
  09 Apr 2011 in Biotech
  
• »New Distribution for Misonix Should Mean Higher Margins and Sales
  09 Apr 2011 in Biotech & Current Market News
  
• »Biotech for the Generalist Investor — Ventrus Bio (VTUS)
  09 Apr 2011 in Biotech & Current Market News
  
• »DARA BioSciences Reports 2010 Results and Corporate Overview
  09 Apr 2011 in Biotech & Current Market News
  
• »Access Pharma Aiming to Aid in Ovarian Cancer Fight
  09 Apr 2011 in Biotech & Current Market News